Shanghai Shyndec Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥14.8B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.2%. Its total assets and total liabilities are CN¥19.9B and CN¥5.1B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.1B making its interest coverage ratio -13.7. It has cash and short-term investments of CN¥6.4B.
Key information
7.2%
Debt to equity ratio
CN¥1.06b
Debt
| Interest coverage ratio | -13.7x |
| Cash | CN¥6.41b |
| Equity | CN¥14.76b |
| Total liabilities | CN¥5.09b |
| Total assets | CN¥19.85b |
Recent financial health updates
Recent updates
Improved Earnings Required Before Shanghai Shyndec Pharmaceutical Co., Ltd. (SHSE:600420) Stock's 33% Jump Looks Justified
May 06
Is Shanghai Shyndec Pharmaceutical (SHSE:600420) A Risky Investment?
Apr 30Solid Earnings May Not Tell The Whole Story For Shanghai Shyndec Pharmaceutical (SHSE:600420)
Apr 05Financial Position Analysis
Short Term Liabilities: 600420's short term assets (CN¥11.2B) exceed its short term liabilities (CN¥4.9B).
Long Term Liabilities: 600420's short term assets (CN¥11.2B) exceed its long term liabilities (CN¥198.6M).
Debt to Equity History and Analysis
Debt Level: 600420 has more cash than its total debt.
Reducing Debt: 600420's debt to equity ratio has reduced from 44.2% to 7.2% over the past 5 years.
Debt Coverage: 600420's debt is well covered by operating cash flow (203.8%).
Interest Coverage: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.